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Introduction
Leukemia inhibitory factor (LIF) is a polyfunctional
cytokine with numerous regulatory effects in vivo and in
vitro. In murine stem cell cultures it is the essential
media supplement for the maintenance of pluripotency
of embryonic and induced pluripotent stem cells. To
explore if the glycosylation and/or other post-transla-
tional modifications are affecting this activity, we pro-
duced and isolated LIF from either eucaryotic cells
(Chinese hamster ovary (CHO) cells) or procaryotes (E.
coli) and compared their biological activities in this
study.
Results
Production in E.coli
To increase the solubility the LIF is expressed together
with thioredoxin as a fusion protein. The genes for the
fusion protein are separated on the vector (pET32b) by
a TEV (Tobacco Etch Virus) protease cleavage site, in
addition thioredoxin is expressed with a his-tag. The
resulting construct was transformed into E.coli BL21
(DE3), which were afterwards cultivated at 23°C. This
relatively low temperature leads to increased solubility
and yield of the target protein. The protein was after-
wards purified from the fermentation broth by metal
chelate affinity chromatography through the utilization
of Zn
2+ ions immobilized on IDA membrane adsorbers.
To cleave the thioredoxin from the fusion protein the
obtained protein fractions were directly treated with
recombinant TEV protease. The released hLIF was puri-
fied from the protein mixture using ion exchange chro-
matography [1].
Production in CHO cells
The utilized CHO
SFS cell line (CCS, Hamburg, Ger-
many) was transducted using a lentivirus with a pRRL
vector, which coded for his-tagged humane LIF. Verifi-
cation of the expression, as well as of the extracellular
localization was carried out by intracellular flow cyto-
metric staining and by western blot. The cultivation in
serum free medium (ProCHO5, Lonza, Basel, Switzer-
land) was initially performed in spinner flasks. After-
wards the scale-up to 1.5 L bioreactor scale was
accomplished. The cultivation was carried out at 37°C,
200 rpm, and pH 7.2. The first step of the purification
of the concentrated supernatant was performed by
metal chelate affinity chromatography, where Ni
2+ ions
were immobilized. Afterwards the pooled protein frac-
tions were purified by a polishing step by heparin affi-
nity chromatography.
Effects on murine iPS suspension cells
Cell growth: The cells were cultivated as cell spheres in
suspension in DMEM medium supplied with 10 ng LIF
per ml. As positive control ESGRO LIF, which is pro-
duced in E.coli, was used. For each of the three LIFs
used as well as for the negative control two cultures of
2 ml each were harvested using trypsin every day and
the cell count was determined manually using trypan
blue. For the long-term cultivation the cells were
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cell density and the viabilities show the activity of the
produced LIFs when compared with the positive and
negative control but no discrepancy in their activities.
Pluripotency maintaining potential: Via flow cytometry
the expression of the pluripotency markers SSEA-1 and
Oct4 was determined using an anti-SSEA-1-PE antibody
and measuring the expression of GFP, which stands
under the control of an Oct4 promoter respectively. For
the negative control an isotype control antibody was
used for SSEA-1. For GFP, the results achieved were
compared to the GFP expression of the cells at the start
of the cultivation. The results show a slight decrease in
SSEA-1 (FL-2) but not GFP (FL-1) expression over the
duration of the cultivation, but no differences regarding
the activities in accordance to the source of the LIFs.
Effects on adherent growing murine ESC
Murine ESC, carrying an Oct4-GFP reporter construct
(OG2-ESC) [2] were seeded on C3H irridatred mouse
embryonic fibroblast cells in 6-well-plates with LIF con-
centrations of 40, 10, and 2.5 ng/ml. As positive control
an E.coli-derived LIF was used, which has been pro-
duced at the MPI Münster and has previously been
tested. The media were changed every 2 days and the
cells were passaged twice a week for 5 passages. After
24 days the cells were harvested and used for qRT-PCR.
Within the qRT-PCR b-Actin was used as the house-
keeping gene. The expression of the pluripotency mar-
kers Oct4 and Nanog as well as marker proteins for the
three germ layers (Trp63 for ectodermal, AFP for endo-
dermal and Brachyury for mesodermal differentiation)
were quantified. The results show that the mesodermal
marker is downregulated, which indicates spontaneous
differentiation of the negative control into the mesoder-
mal germ layer. Between the used LIFs no significant
differences could be determined.
Effects on murine ES suspension cells
Cell growth: The procedure was in accordance to the
approach with the iPS cells and the three LIFs were also
used in concentrations of 100 and 1 pg each. Supplemen-
tary the amount of apoptosis was measured after four days
of culture using the Annexin-V Kit (Invitrogen, Carlsbad,
CA, USA) for flow cytometry. The results clearly show
activity for the concentrations of 10 ng (figure 1) and 100
pg but no considerably difference from the negative con-
trol for the concentration of 1 pg and also no differences
for the LIFs regarding their sources were found.
Pluripotency maintaining potential: The marker pro-
tein SSEA-1 was measured flow cytometrically once a
week for the culture containing 10 ng/ml LIF as well as
once after 14 days for the one containing 1 pg. The
SSEA-1 expression remains at a level of above 97%
when 10 ng LIF/ml were used, but is broadly decreased
for the negative control. For the concentration of 1 pg
LIF/ml SSEA-1 expression levels of about 90% after 14
days were achievable although this amount of LIF
showed no differences from the negative control in
regards of cell viability. From these results we can state
that with regard to the pluripotency maintaining poten-
tial the different LIF did not show detectable differences.
Conclusion
The production and isolation of LIF from E.coli as well
as from CHO cells was successfully established. The
bioactivity of both proteins was demonstrated in various
experiment using different cells and methods of detec-
Figure 1 Living cell count and viability against the cultivation time for the cultivation of the ES cells with 10 ng LIF/ml.
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malian cells and LIF from prokaroytes are equally
effective.
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